CS, K., AF, Z., & SS, H. (2021). CYP2C19 Genotype-Guided Antiplatelet Therapy Among Asian Patients with Ischaemic Stroke. Clinical drug investigation, 41(1), 115. https://doi.org/10.1007/s40261-020-00985-5
Chicago Style (17th ed.) CitationCS, Kow, Zaihan AF, and Hasan SS. "CYP2C19 Genotype-Guided Antiplatelet Therapy Among Asian Patients with Ischaemic Stroke." Clinical Drug Investigation 41, no. 1 (2021): 115. https://doi.org/10.1007/s40261-020-00985-5.
MLA (9th ed.) CitationCS, Kow, et al. "CYP2C19 Genotype-Guided Antiplatelet Therapy Among Asian Patients with Ischaemic Stroke." Clinical Drug Investigation, vol. 41, no. 1, 2021, p. 115, https://doi.org/10.1007/s40261-020-00985-5.
Warning: These citations may not always be 100% accurate.